Skip to content
DataLookout
Menu

MgScaf-PBDNCT07906730

Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Bone Union Rate
Timeframe: 48 weeks after surgery

Secondary (9)

Barthel Index Score for Activities of Daily Living
Patient-Rated Wrist Evaluation (PRWE) Score
Hospital for Special Surgery (HSS) Knee Score
American Shoulder and Elbow Surgeons (ASES) Score
Constant-Murley Shoulder Score
Show 4 moreShow less
Incision Healing Grade
Number of Participants Meeting All Four Device Performance Criteria
Distribution of Participants by CT-Assessed Magnesium Alloy Scaffold Degradation Grade at Week 24
Distribution of Participants by CT-Assessed Magnesium Alloy Scaffold Degradation Grade at Week 48

Arms and interventions

Magnesium Alloy Scaffold GroupExperimental

Participants will undergo open reduction and internal fixation. A customized biodegradable magnesium alloy scaffold with controlled degradation will be implanted into the periarticular bone defect to provide structural support, followed by plate-and-screw fixation.

Calcium Sulfate GroupActive comparator

Participants will undergo conventional open reduction and internal fixation. The periarticular bone defect will be filled with calcium sulfate bone graft substitute.

Devices: Magnesium Alloy Scaffold, Calcium Sulfate Bone Graft Substitute

Sites

4 sites in 1 country